{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-019256","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2025-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.913901+00:00","generated_at":"2026-05-27T04:03:55.519519+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Aligos Therapeutics appoints Lesley Ann Calhoun as COO while retaining CFO role","bullets":["Lesley Ann Calhoun appointed COO effective January 30, 2025, adding to existing CFO role.","She has served as EVP and CFO since June 2020; prior roles at Global Blood Therapeutics and Hyperion Therapeutics.","Calhoun brings over 30 years of finance and operations experience, including audit at Deloitte & Touche."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-019256","json":"https://secwatch.observer/filing/0001193125-25-019256.json","markdown":"https://secwatch.observer/filing/0001193125-25-019256.md","text":"https://secwatch.observer/filing/0001193125-25-019256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312525019256/0001193125-25-019256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312525019256/d860038d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T04:03:55.519519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cd23445dfe","claim":"Lesley Ann Calhoun was appointed as Chief Operating Officer at Aligos Therapeutics, Inc..","evidence_excerpt":"On January 30, 2025, the Board of Directors of Aligos Therapeutics, Inc. (the “Company”) appointed Lesley Ann Calhoun as the Company’s Chief Operating Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312525019256/0001193125-25-019256-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}